Clinical Trial Update: Efficacy and Safety Study of Combination Therapy With Docetaxel-oxaliplatin-capecitabine in Patients With Advanced Gastric Adenocarcinoma and Intermediate General Status [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluates the efficacy and safety of a docetaxel-oxaliplatin-capecitabine combination in patients with advanced gastric adenocarcinoma and in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma
• Gastric Cancer

Drugs mentioned

• Capecitabine (Xeloda) (Capecitabine)
• Docetaxel (Taxotere) (docetaxel)
• Oxaliplatin (Eloxatin) (oxaliplatin)

Snippet

Sponsor: Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) | Conditions: Gastric Cancer | Phase 2 | Status: COMPLETED